Search

1. Searching for savings in Medicare drug price negotiations

Author(s):

Cubanski, Juliette, author
Neuman, Tricia, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, April 2018

Subject(s):

Drug Costs
Medicare Part D -- economics
Negotiating
Prescription Drugs -- economics
United States

2. How does the Trump Administration drug pricing blueprint affect Medicaid?

Author(s):

Young, Katherine, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, May 2018

Subject(s):

Cost Control
Drug Costs
Medicaid -- economics
Prescription Drugs -- economics
United States
United States.

3. Summary of recent and proposed changes to Medicare prescription drug coverage and reimbursement

Author(s):

Cubanski, Juliette, author

Publication:

Menlo Park, CA : Henry J. Kaiser Family Foundation, February 2018

Subject(s):

Medicare Part B -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
United States

4. Rx watchdog report: drug prices continue to climb despite lack of growth in general inflation rate

Publication:

Washington, D.C. : AARP Public Policy Institute, c2009

Subject(s):

Drug Costs -- statistics & numerical data
Drug Costs -- trends
Drug Industry -- economics
Inflation, Economic -- statistics & numerical data
Inflation, Economic -- trends
Prescription Drugs -- economics

5. Rx watchdog report: brand name drug prices continue to climb despite low general inflation rate

Publication:

Washington, D.C. : AARP Public Policy Institute, c2010

Subject(s):

Drug Costs -- trends
Prescription Drugs -- economics
United States

6. Getting to lower prescription drug prices: the key drivers of costs and what policymakers can do to address them

Author(s):

Waxman, Henry A., author
Corr, Bill, author
Sharp, Jeremy, author
McDonald, Ruth, author
Kenyatta, Kahaari, author

Publication:

[New York, New York] : The Commonwealth Fund, October 2020

Subject(s):

Drug Costs
Prescription Drugs -- economics
Cost Control
Health Policy
United States

7. Medicaid's most costly outpatient drugs

Author(s):

Young, Katherine, author
Rudowitz, Robin, author
Garfield, Rachel, author
Musumeci, MaryBeth, author

Publication:

Menlo Park, CA : Henry J. Kaiser Family Foundation, July 2016

Subject(s):

Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicaid -- economics
Prescription Drugs -- economics
United States

8. Filling the Medicaid gap with a public option

Author(s):

Holahan, John, author
Simpson, Michael, author

Publication:

Washington, DC : Urban Institute, October 2021

Subject(s):

Health Care Reform -- legislation & jurisprudence
Medicaid -- economics
Medically Uninsured -- statistics & numerical data
Poverty -- statistics & numerical data
Prescription Drugs -- economics
United States
United States.

9. Prescription drugs: U.S. prices for selected brand drugs were higher on average than prices in Australia, Canada, and France : report to the Chairman, Committee on the Budget, U.S. Senate

Publication:

Washington, DC : United States Government Accountability Office, March 2021

Subject(s):

Costs and Cost Analysis
Government Regulation
Medicare Part D -- economics
Prescription Drugs -- economics
United States

10. Drug price increases that exceed inflation are costing Medicare Part D billions

Author(s):

Purvis, Leigh, author

Publication:

Washington, DC : AARP Public Policy Institute, June 2021

Subject(s):

Drug Costs
Inflation, Economic
Medicare Part D -- economics
Medicare Part D -- trends
Prescription Drugs -- economics
United States